Axicabtagene ciloleucel (Yescarta) received accelerated FDA approval on March 5, 2021, for the treatment of adult patients with relapsed or refractory FL after 2 or more lines of systemic therapy.
Jennifer Gershman, PharmD
Advertisement
Articles by Jennifer Gershman, PharmD
Conjunctivitis, commonly referred to as pink eye, involves inflammation of the outer layer of the eye and inside of the eyelid.
Advertisement
Latest Updated Articles
- Conjunctivitis 101
Published: May 3rd 2018 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Blenrep Receives FDA Approval for Treatment of Relapsed or Refractory Multiple Myeloma
2
Two Doses of PCV20 in Lymphoma Survivors Elicits Greater Humoral Response
3
Addressing Burnout in Pharmacy Residency: A Comprehensive Approach to Enhancing Well-Being
4
CHEST 2025: Advancing Respiratory Virus Vaccines and Improving Uptake Among High-Risk Populations
5
